ReviewSmart medicine2026
Advances in Hydrogel Tissue Engineering for Spinal Cord Injury Repair.
Review in Smart medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modulation of the TGF-β/Smad Signaling Pathway by a Bioactive Oxidized Polygonati Rhizoma Polysaccharide Crosslinked Chitosan Hydrogel as Therapeutic Carrier for Parkinson's Disease Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI), which is a severe complication of spinal fractures, often causes the dysfunction of the spinal cord and results in sensory and motor abnormalities. Current clinical treatments-including medication, decompression surgery, and bed rest-remain insufficient for complete functional recovery. It is necessary to reduce the early inflammatory reactions, rebuild the connections of neurons, and reduce the formation of the glial scar in order to restore spinal cord function. With the development of biomaterials discipline, hydrogel tissue engineering has become an effective and feasible method. Injectable and highly biocompatible hydrogel can directly fill the injured site as a scaffold material that can provide physical support to reduce scar formation and promote axon growth. In addition, hydrogels have the ability to regulate pathophysiological events. For example, it can reduce inflammatory reactions, inhibit glial scar formation, and promote axonal growth, so as to achieve the recovery of motor function after SCI. This review systematically correlates the four pathological phases of SCI with the stage-specific biological functions of hydrogels. It summarizes the current state of research in SCI and hydrogel-based tissue engineering, and discusses the key challenges and future directions in this evolving field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.